home / stock / konef / konef news


KONEF News and Press, KetamineOne Capital Limited

Stock Information

Company Name: KetamineOne Capital Limited
Stock Symbol: KONEF
Market: OTC
Website: wellbeingdigital.co

Menu

KONEF KONEF Quote KONEF Short KONEF News KONEF Articles KONEF Message Board
Get KONEF Alerts

News, Short Squeeze, Breakout and More Instantly...

KONEF - Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...

KONEF - Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group

Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) ( NEO: MEDI ) ( OTC: KONEF ) ( FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psych...

KONEF - Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...

KONEF - Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response

A randomized, triple-blind, placebo-controlled clinical trial involving supplementation with UP360 provides evidence for a robust, healthy immune response in healthy adults following influenza vaccination. Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ ...

KONEF - Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...

KONEF - Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...

KONEF - Wellbeing Announces Cease Trade Order

Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ) announces that the British Columbia Securities Commission (the “ BCSC ”) has issued a Failure-to-File Cease Trade Order (...

KONEF - Wellbeing Digital to Participate at the Benzinga Psychedelic Capital Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...

KONEF - Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...

KONEF - Wellbeing Digital to Participate in The Global Biomedical Design Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychede...

Next 10